[144] EQUIFAX INC SEC Filing

Rhea-AI Filing Summary

Equifax Inc. filed a Form 144 notice for a proposed sale of 49,345 common shares. The filing lists Fidelity Brokerage Services as broker and an aggregate market value of $11,404,110.96, with an approximate sale date of 10/27/2025 on the NYSE.

The shares to be sold reflect prior acquisitions: 21,386 shares from restricted stock vesting on 05/04/2021 (compensation) and 27,959 shares tied to an option granted on 02/21/2020, with cash payment dated 10/27/2025. Shares outstanding were 122,394,037; this is a baseline figure, not the amount being sold.

The filing also notes a sale during the prior three months: Mark W. Begor sold 48,264 common shares on 07/28/2025 for gross proceeds of $11,666,012.59.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	49345	11404110.96	122394037	10/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2021	Restricted Stock Vesting	Issuer			21386	05/04/2021	Compensation
Common	10/27/2025	Option Granted - 02/21/2020	Issuer			27959	10/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark W. Begor 1550 Peachtree Street N.W. Atlanta GA 30309	Common	07/28/2025	48264	11666012.59

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Equifax (EFX) disclose in this Form 144?

A proposed sale of 49,345 common shares with an aggregate market value of $11,404,110.96 to be sold on the NYSE.

When is the proposed sale date for EFX shares?

The filing lists an approximate sale date of 10/27/2025.

Who is the broker for the proposed EFX share sale?

The broker named is Fidelity Brokerage Services LLC.

How many Equifax shares are outstanding?

122,394,037 shares are stated as outstanding; this figure is a baseline and separate from the proposed sale amount.

What prior acquisitions relate to the EFX shares being sold?

21,386 shares from restricted stock vesting (05/04/2021) and 27,959 shares from an option granted (02/21/2020) with cash payment on 10/27/2025.

Were there recent EFX insider sales noted?

The filing lists a prior sale: Mark W. Begor sold 48,264 shares on 07/28/2025 for $11,666,012.59 in gross proceeds.

On which exchange will the EFX shares be sold?

The filing names the NYSE as the exchange.